Description: Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Home Page: www.biocon.com
20th KM Hosur Road
Bengaluru,
560100
India
Phone:
91 80 2808 2808
Officers
| Name | Title |
|---|---|
| Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc. | Founder & Executive Chairperson |
| Mr. Siddharth Mittal BCom, CA, CPA | MD, CEO & Director |
| Mr. Peter James Jonathan Bains | Group Chief Executive Officer |
| Mr. Mukesh Kamath | Chief Financial Officer |
| Mr. Arun Gupta | Head of Operations |
| Mr. Atanu Roy | Group Chief Information Officer |
| Mr. Saurabh Paliwal | Head of Investor Relations |
| Mr. Mayank Verma | Company Secretary & Compliance Officer |
| Ms. Seema Shah Ahuja BA, MBA | Global Head of Communications & Corporate Brand |
| Ms. Maninder Kapoor Puri | Head of Human Resources |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 31.6445 |
| Price-to-Book MRQ: | 2.1682 |
| Price-to-Sales TTM: | 3.0508 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 16315 |